Remote consultations for diabetes care in a post COVID-19 world

Remote consultations have greatly facilitated the delivery of healthcare in the United Kingdom (UK) over the last 24 months. During the first lockdown in response to the COVID-19 pandemic in March 2020, healthcare professionals (HCPs) were forced to conduct most outpatient clinical activity by telephone or video. In the Type 1 Diabetes Exchange Quality Improvement collaborative, telemedicine visits increased from <1% pre-pandemic to 95% in April 2020, representing a near total digitalisation of type 1 diabetes care delivery amongst clinics in this network, during this time.1 More recently, while many other aspects of care have gradually returned to normal, there is a debate about the best way in which to continue to use remote consultations to complement traditional face-to-face visits into the future.